Cargando…
Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066840/ https://www.ncbi.nlm.nih.gov/pubmed/21450771 http://dx.doi.org/10.1136/bmjqs.2010.046227 |
_version_ | 1782201120815316992 |
---|---|
author | Dixon-Woods, Mary Amalberti, Rene Goodman, Steve Bergman, Bo Glasziou, Paul |
author_facet | Dixon-Woods, Mary Amalberti, Rene Goodman, Steve Bergman, Bo Glasziou, Paul |
author_sort | Dixon-Woods, Mary |
collection | PubMed |
description | Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or pose risks, while other innovations that could potentially deliver benefits to patients remain slow to achieve uptake. Second, participatory, cooperative approaches may be the best way of achieving sustainable, positive innovation, yet relying solely on such approaches may disrupt positive innovation. Third, improvement clearly depends upon change, but change always generates new challenges. Quality improvement systems may struggle to keep up with the pace of innovation, yet evaluation of innovation is often too narrowly focused for the system-wide effects of new practices or technologies to be understood. A new recognition of the problems of innovation is proposed and it is argued that new approaches to addressing them are needed. |
format | Text |
id | pubmed-3066840 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-30668402011-04-11 Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new Dixon-Woods, Mary Amalberti, Rene Goodman, Steve Bergman, Bo Glasziou, Paul BMJ Qual Saf The Social Determinants of Action Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or pose risks, while other innovations that could potentially deliver benefits to patients remain slow to achieve uptake. Second, participatory, cooperative approaches may be the best way of achieving sustainable, positive innovation, yet relying solely on such approaches may disrupt positive innovation. Third, improvement clearly depends upon change, but change always generates new challenges. Quality improvement systems may struggle to keep up with the pace of innovation, yet evaluation of innovation is often too narrowly focused for the system-wide effects of new practices or technologies to be understood. A new recognition of the problems of innovation is proposed and it is argued that new approaches to addressing them are needed. BMJ Group 2011-04 /pmc/articles/PMC3066840/ /pubmed/21450771 http://dx.doi.org/10.1136/bmjqs.2010.046227 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | The Social Determinants of Action Dixon-Woods, Mary Amalberti, Rene Goodman, Steve Bergman, Bo Glasziou, Paul Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title | Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title_full | Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title_fullStr | Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title_full_unstemmed | Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title_short | Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
title_sort | problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new |
topic | The Social Determinants of Action |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066840/ https://www.ncbi.nlm.nih.gov/pubmed/21450771 http://dx.doi.org/10.1136/bmjqs.2010.046227 |
work_keys_str_mv | AT dixonwoodsmary problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew AT amalbertirene problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew AT goodmansteve problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew AT bergmanbo problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew AT glaszioupaul problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew |